09-07-2012: Alain Schwenck, 51, has joined Genethon as Director of Genethon Bioprod, the new site for the production of clinical grade-gene therapy medicines for the treatment of rare diseases, created by AFM-Telethon. Mr. Schwenck is a seasoned expert in manufacturing of pharmaceutical products. He began his career at Rhône Poulenc, and has since then managed several manufacturing plants for leading institutions in the pharmaceutical industry: Lilly France, the Laboratoire Français du Fractionnement et des Biotechnologies (LFB), Bristol-Myers Squibb France and the Laboratoires Salem. Mr. Schwenck obtained his engineering degree from the French engineering school École Nationale Supérieure des Arts et Métiers. He also holds a business degree from the international business school École Supérieure de Commerce de Paris (ESCP).